Thomas KLEIN;Maximilian von EYNATTEN;Gerd LUIPPOLD;Uli BROEDL;Odd-Erik JOHANSEN
发明人:
Uli BROEDL,Maximilian von EYNATTEN,Odd-Erik JOHANSEN,Thomas KLEIN,Gerd LUIPPOLD
申请号：
US13539713
公开号：
US20130035298A1
申请日:
2012.07.02
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The invention relates to the treatment or prevention of renal impairment and/or complications using a SGLT-2 inhibitor, for example in patients diagnosed with metabolic disorders and related conditions.
